Kanwar S, Woodman R C, Poon M C, Murohara T, Lefer A M, Davenpeck K L, Kubes P
Immunology Research Group, University of Calgary, Alberta, Canada.
Blood. 1995 Oct 1;86(7):2760-6.
Desmopressin, (DDAVP; 1-desamino-8-D-arginine vasopressin) increases the release and activity of von Willebrand factor (vWF); however, its effects on the other major constituent of endothelial Weibel-Palade bodies, P-selectin, has not been investigated. DDAVP-induced P-selectin expression may explain DDAVP's efficacy in bleeding disorders in which vWF levels are normal. Therefore, the objective of this study is to assess the effect of DDAVP on P-selectin expression on endothelial cells of postcapillary venules in vivo and on human umbilical vein endothelium in vitro, and to determine whether DDAVP has direct effects on leukocyte behavior in postcapillary venules. DDAVP (0.1 and 1.0 microgram/mL) induced a significant but transient increase in P-selectin expression on human umbilical vein endothelial cells as well as on rat and human platelets. Immunohistochemical analysis of rat postcapillary venules showed that in contrast to saline, DDAVP injection (1 microgram/kg, intravenous) induced significant endothelial P-selectin expression. DDAVP administration also induced a rapid and significant increase in leukocyte rolling in rat mesenteric venules in vivo. This response was entirely dependent on P-selectin, as an anti-P-selectin antibody rapidly reversed the DDAVP-induced increase in leukocyte rolling. DDAVP induced leukocyte rolling in medium (20 to 40 microns) and large (> 40 microns), but not small (< 20 microns), postcapillary venules. In animals that were treated with DDAVP, there was a steady and significant increase in leukocyte adhesion. This study shows that DDAVP can directly induce P-selectin expression on endothelium in vitro and in vivo and that the latter response is capable of supporting prolonged leukocyte rolling in rat postcapillary venules.
去氨加压素(DDAVP;1-去氨基-8-D-精氨酸加压素)可增加血管性血友病因子(vWF)的释放及活性;然而,其对内皮细胞Weibel-Palade小体的另一种主要成分P-选择素的影响尚未得到研究。DDAVP诱导的P-选择素表达可能解释了DDAVP在vWF水平正常的出血性疾病中的疗效。因此,本研究的目的是评估DDAVP对体内毛细血管后微静脉内皮细胞及体外人脐静脉内皮细胞上P-选择素表达的影响,并确定DDAVP是否对毛细血管后微静脉中的白细胞行为有直接作用。DDAVP(0.1和1.0微克/毫升)可诱导人脐静脉内皮细胞以及大鼠和人血小板上P-选择素表达显著但短暂增加。对大鼠毛细血管后微静脉的免疫组织化学分析显示,与生理盐水相比,静脉注射DDAVP(1微克/千克)可诱导显著的内皮P-选择素表达。给予DDAVP还可在体内诱导大鼠肠系膜微静脉中白细胞滚动迅速且显著增加。这种反应完全依赖于P-选择素,因为抗P-选择素抗体可迅速逆转DDAVP诱导的白细胞滚动增加。DDAVP在中等大小(20至40微米)和大的(>40微米)但不在小的(<20微米)毛细血管后微静脉中诱导白细胞滚动。在用DDAVP治疗的动物中,白细胞黏附持续且显著增加。本研究表明,DDAVP可在体外和体内直接诱导内皮细胞上P-选择素的表达,且后者的反应能够支持大鼠毛细血管后微静脉中白细胞的长时间滚动。